CareCloud, Inc.

NASDAQ:CCLD

Medical - Healthcare Information Services

Healthcare
$2.38 +1.60%

+$0.04 today

Market cap
$101.27M
Beta
1.51
P/E (TTM)
9.7
EPS (TTM)
$0.23
52W Low $2.09High $4.01

Volume 0.53M

Average 0.58M

CCLD Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

CareCloud, Inc.NASDAQ: CCLD

Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026

Capital expenditures declines year over year

Q1 FY2026 capital expenditures of $1.23M (cash outflow) fell 16.2% year over year, ahead of the -89.3% change in trailing-twelve-month capital expenditures. Over 3 fiscal years it compounded at -12.0% a year.

Context

  • Capital expenditures amounted to 6.7% of revenue in FY2025, up 5.1 pp from a year earlier.
  • Capital expenditures grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -16.2% holds above the trailing-twelve-month pace of -89.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$1.23M-146.4% QoQ
Last fiscal yearDec 2025
-$8.03M+373.0% YoY
LTMMar 2026
-$608K-89.3% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-16.2%——
1 year+373.0%——
3-year CAGR-12.0%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(8.03M) USD
Year-over-year change
-373.0%

Capital Expenditures vs competitors

How CCLD compares with its peers on the latest reported figures

  • CCLD's LTM Mar 2026 capital expenditures of $608K is the 5th largest of the 10 companies compared; the peer median is $319K.
  • Its year-over-year change of -89.3% is the 6th highest of 7, against a peer median of -35.2%.
  • Capital expenditures amounts to 0.5% of revenue for CCLD, versus a peer median of 2.5%.
CCLD Competitors Peer median
Capital Expenditures for CCLD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SEERSeer, Inc.LTM Mar 2026$1.41M -59.4%-44.1%9.4%
JYNTThe Joint Corp.LTM Mar 2026$1.41M +25.4%-36.6%2.5%
APYXApyx Medical CorporationLTM Mar 2026$1.12M +50.8%+3.3%2.0%
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026$925K -15.8%-49.9%2.7%
CCLDCareCloud, Inc.LTM Mar 2026$608K -89.3%-12.0%0.5%
LUCDLucid Diagnostics Inc.LTM Mar 2026$319K -54.6%-39.9%6.2%
HURATuHURA Biosciences, Inc.LTM Mar 2026$82.26K —-31.0%—
AGENAgenus Inc.LTM Mar 2026$1K -99.8%-77.9%0.0%
TTRXTurn Therapeutics Inc.LTM Mar 2026$10 ———
IRDOpus Genetics, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding CCLD) $319K-35.2%-39.9%2.5%

Competitors are the stored peer set for CCLD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income2.84M5.43M(48.67M)7.85M10.8M
Depreciation & Amortization16.25M15.6M17.04M16.46M16.98M
Deferred Income Tax289K76K(525K)00
Stock-Based Compensation5.4M4.91M4.89M115K454K
Change in Working Capital(10.79M)(4.03M)(1.11M)(4.55M)454K
Accounts Receivables(1.24M)1.82M1.55M(460K)346K
Inventory(104K)122K(84K)(109K)67K
Accounts Payables(10.37M)(6.59M)(3.26M)(4.65M)1.27M
Other Working Capital921K619K682K673K(1.23M)
Other Non-Cash Items(648K)(842K)43.84M759K(120K)
Operating Cash Flow13.33M21.15M15.46M20.64M28.56M
Capital Expenditures(10.56M)(11.77M)(11.61M)(1.7M)(8.03M)
Acquisitions (Net)(12.58M)000(16.51M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(7.64M)(9.18M)(8.55M)(5.71M)(3.25M)
Investing Cash Flow(23.15M)(11.77M)(11.61M)(7.41M)(24.54M)
Debt Repayment6.88M(1M)1.11M(10.68M)832K
Common Stock Issued9.17M0000
Common Stock Repurchased000(579K)0
Dividends Paid(14.44M)(15.31M)(14.3M)0(6.3M)
Other Financing Activities(2.12M)(2.23M)(1.52M)0(148K)
Financing Cash Flow(519K)(7.65M)(13.29M)(11.26M)(5.61M)
Effect of Forex Changes(254K)225K469K(166K)57K
Net Change in Cash(10.59M)1.96M(8.97M)1.81M(1.53M)
Free Cash Flow2.77M9.38M3.85M18.95M20.53M

CareCloud, Inc.

NASDAQ:CCLD

Intrinsic Alpha fair value

Locked

Current Price

$2.38

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.